☆ 4.2 Article

Natural cubic splines for the analysis of Alzheimer's clinical trials

PHARMACEUTICAL STATISTICS (2023)

Related references

Note: Only part of the references are listed.

Article Mathematical & Computational Biology

Progression models for repeated measures: Estimating novel treatment effects in progressive diseases

Lars Lau Raket

Summary: Mixed models for repeated measures (MMRMs) are commonly used in clinical trials, but their linearity limits their ability to estimate treatment effects. This article introduces a nonlinear mixed-effects model called progression models for repeated measures (PMRMs), which allows for estimation of alternative types of treatment effects, such as slowing or delaying disease progression. Compared to conventional models, PMRMs provide better interpretability and clinical meaningfulness.

STATISTICS IN MEDICINE (2022)

Add to Collection

Article Clinical Neurology

Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease

Guoqiao Wang et al.

Summary: This article proposes the use of proportional cLDA and proportional MMRM as analysis models for disease progression, which can increase power while maintaining type I error control, and provides various possibilities for modeling longitudinal data.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

Stephen Salloway et al.

Summary: Results from the phase 2/3 clinical trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease show no cognitive benefits despite reduced amyloid plaques and other key biomarkers with gantenerumab. Solanezumab did not show cognitive benefits and even led to greater decline on some measures, with no benefits on downstream biomarkers. Gantenerumab significantly reduced amyloid plaques and some biomarkers but did not slow cognitive decline in symptomatic DIAD patients.

NATURE MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach

Michael C. Donohue et al.

ALZHEIMERS & DEMENTIA (2020)

Add to Collection

Article Mathematical & Computational Biology

Aligning Treatment Policy Estimands and Estimators-A Simulation Study in Alzheimer's Disease

Elena Polverejan et al.

STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2020)

Add to Collection

Article Clinical Neurology

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia A Randomized Clinical Trial

Suzanne Craft et al.

JAMA NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease A Randomized Clinical Trial

Christopher H. van Dyck et al.

JAMA NEUROLOGY (2019)

Add to Collection

Article Mathematical & Computational Biology

A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease

Guoqiao Wang et al.

STATISTICS IN MEDICINE (2018)

Add to Collection

Article Clinical Neurology

The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model

Randall J. Bateman et al.

ALZHEIMERS & DEMENTIA (2017)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Fitting Linear Mixed-Effects Models Using lme4

Douglas Bates et al.

JOURNAL OF STATISTICAL SOFTWARE (2015)

Add to Collection

Article Statistics & Probability

mice: Multivariate Imputation by Chained Equations inR

Stef van Buuren et al.

Journal of Statistical Software (2015)

Add to Collection

Article Clinical Neurology

The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline

Michael C. Donohue et al.

JAMA NEUROLOGY (2014)

Add to Collection

Article Pharmacology & Pharmacy

On the practical application of mixed effects models for repeated measures to clinical trial data

Scott W. Andersen et al.

PHARMACEUTICAL STATISTICS (2013)

Add to Collection

Article Biology

On Efficiency of Constrained Longitudinal Data Analysis Versus Longitudinal Analysis of Covariance

Kaifeng Lu

BIOMETRICS (2010)

Add to Collection

Article Medicine, General & Internal

Vitamin E and donepezil for the treatment of mild cognitive impairment

RC Petersen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Article Statistics & Probability

Local polynomial mixed-effects models for longitudinal data

HL Wu et al.

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)

Add to Collection

Article Biology

Nonparametric mixed effects models for unequally sampled noisy curves

JA Rice et al.

BIOMETRICS (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.